ThinkstockHumana Inc. (NYSE: HUM) reported its second-quarter financial results Wednesday before the markets opened. The company had $1.67 in earnings per share (EPS) on $13.73 billion in revenue compared to Thomson Reuters consensus estimates…
ThinkstockAnthem, Inc. (NYSE: ANTM) reported its second-quarter financial results Wednesday before the markets opened. The company had $3.10 in earnings per share (EPS) on $19.76 billion in revenue compared to Thomson Reuters consensus estimates…
ThinkstockDermira, Inc. (NASDAQ: DERM) filed an S-1 form with the Securities and Exchange Commission (SEC) for a secondary offering. There were no terms given in this initial filing but the proposed maximum price is…
courtesy of TwitterTwitter Inc. (NYSE: TWTR) released its second-quarter earnings report after the market closed on Tuesday. The social media company had $0.07 in earnings per share (EPS) on $502 million in revenue versus…
courtesy of Gilead SciencesGilead Sciences Inc. (NASDAQ: GILD) reported second-quarter financial results Tuesday after the markets closed. The biotech giant had $3.15 in earnings per share (EPS) on $8.2 billion in revenue compared to…
courtesy of T-Mobile US Inc.T-Mobile U.S., Inc. (NYSE: TMUS) announced its new promotion on Tuesday the “Un-carrier Amped” upgrades. There were already a series of plans released but this most recent one takes the…
Wikimedia CommonsAltria Group Inc. (NYSE: MO) is set to report its second-quarter financial results Wednesday before the markets open. The consensus estimates from Thomson Reuters call for $0.71 in earnings per share (EPS) on…
ThinkstockNantKwest (NASDAQ: NK) entered the market Tuesday with its initial public offering (IPO). The stock priced early Tuesday morning at $25 per share coming over the top of the expected price range of $20…
ThinkstockBelgian pharmaceutical group UCB announced Tuesday morning that its phase 3 trial for lupus treatment epratuzumab failed to produce statistically significant results in both dosages tested in Systemic Lupus Erythematosus (SLE). The developer said…
GrubHub SEC FilingGrubHub Inc. (NYSE: GRUB) reported its second quarter financial results Tuesday before the markets opened. The company had $0.17 in earnings per share (EPS) on $88.0 million in revenue compared to Thomson Reuters…
Wikimedia CommonsTwitter, Inc. (NYSE: TWTR) is scheduled to report earnings after the markets close on Tuesday. The consensus estimates from Thomson Reuters call for $0.04 in earnings per share (EPS) on $481.28 million in…
courtesy of BaiduBaidu, Inc. (NASDAQ: BIDU) reported second-quarter financial results before U.S. markets opened Tuesday as $1.81 in earnings per American Depositary Share (ADS) on $2.67 billion in revenue compared to consensus estimates of $1.87 in earnings…
General Motors Co.General Motors Co. (NYSE: GM) is in a very strong position looking to the future. The company has open avenues to pursue both domestically and in China. With this position, and with…
ThinkstockMerck & Co. Inc. (NYSE: MRK) reported its second-quarter financial results Tuesday before the markets opened. The pharmaceutical giant had $0.86 in earnings per share (EPS) on $9.8 billion in revenue compared to Thomson…
Wikimedia CommonsSirius XM Holdings Inc. (NASDAQ: SIRI) released its second-quarter earnings report Tuesday before the markets opened. The company had $0.03 in earnings per share (EPS) on $1.12 billion in revenue versus Thomson Reuters…
Republic Airways HoldingsRepublic Airways Holdings Inc. (NASDAQ: RJET) is under the gun of the U.S. Federal Aviation Administration (FAA). The organization has boosted the required flight experience for first officers by a multiple of…
ThinkstockNymox Pharmaceutical Corp. (NASDAQ: NYMX) was one of the best performers on Monday despite a down day in the market. And Nymox is absolutely dominating in 2015 in terms of its performance, as of Friday’s…
courtesy of TwitterTwitter, Inc. (NYSE: TWTR) is scheduled to report its second-quarter financial results on Tuesday. The consensus estimates from Thomson Reuters call for $0.04 in earnings per share (EPS) on $481.13 million in…
ThinkstockMerck & Co. Inc. (NYSE: MRK) reports on Tuesday morning comes into earnings with shares up only 2.7% or so year to date, and up only about 1.7% from a year ago. Thomson Reuters…
ThinkstockRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NYSE: SNY) announced last Friday that the U.S. Food and Drug Administration (FDA) approved Praluent (alirocumab) Injection. Praluent is indicated as an adjunct to diet and maximally…